Antifungal Drugs Market to 2027 - Global Analysis and Forecasts By Infection Type (Superficial Fungal Infection, Systemic Fungal Infection); Drug Type (Echinocandins, Azoles, Polyenes, Allylamines, Others); Therapeutic Indication (Aspergillosis, Dermatophytosis, Candidiasis, Others); Dosage form (Drugs, Ointment, Powder, Others), and Geography
- THE3243835
- 169 Pages
- July 2019
- Pharmaceuticals
The market is driven by the factors such as, rising incidences for the fungal infection of the skin, nails and hair, increasing incidences of cancers, HIV, and hospital-acquired infections and favorable government initiatives to combat the antifungal diseases are likely to drive the growth of the Antifungal Drugs market. However, lack of awareness regarding the fungal infections may restrict the growth of Antifungal Drugs market.
The significantly rising incidences of the fungal infections among others are the leading factors for the market growth.
There are millions of various types of fungi on Earth, but only around 300 are identified as the one who makes people sick. Fungal infections are mainly caused due to microscopic fungi, which is common in the atmosphere. Fungi live outside in soil and on plants and various indoor surfaces and human skin.
The rising number of fungal infections are causing harm to patients. Candidemia is among the most common bloodstream infections in the United States. For instance, according to the Centers for Disease Control and Prevention (CDC), from 2013 to 2017, the average incidence of fungal infection was around 9 per 100,000 people. Though, this number changes as per the geographic location and patient population. CDC predicts that approximately 25,000 cases of candidemia occur across the country per year.
There has been significant variation in the rates of candidemia by age group. The rates have reduced considerably in infants, but it remains higher as compared to other groups. Candidemia rates are majorly high in people aged above 65 and older. The reasons for the difference in incidence by age, race may be due to the alteration in underlying circumstances, socioeconomic status, and other factors. The prevalence of Candidaemia in established countries has been related to the age of patients. The below is the country estimated burden of Candidaemia.
Moreover, due to the tropical climate, South Asia has a high frequency of fungal infections. For instance, according to a report published by Down To Earth organization in 2015, infection from yeast, which is a type of fungus, is 0.8 among 1,000 patients in the US. Moreover, the incidence is found to be 0.2 and 0.9 per 1,000 patients in Europe and Australia, respectively. However, in India, approximately, 1-12 cases occur in every 1,000 patients that are affected by the fungal infection. Therefore, demand for the anti-fungal drugs is increasing owing to providing treatment and helps in maintaining the proper immunity to the patients. Thus, the rising rate of fungal infections are likely to drive the market for anti-fungal drugs in the coming years
Some of the major primary and secondary sources included in the report for the Antifungal Drugs market are World Health Organization, National Institute of Health and Medical Research, Centers for Disease Control and Prevention, The New England Journal of Medicine, Journal of Fungi among the others.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Antifungal Drugs Market – By Infection Type
1.3.2 Global Antifungal Drugs Market – By Drug Type
1.3.3 Global Antifungal Drugs Market – By Therapeutic Indication
1.3.4 Global Antifungal Drugs Market – By Dosage Form
1.3.5 Global Antifungal Drugs Market – By Geography
2. Global Antifungal Drugs Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Antifungal Drugs– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific– PEST Analysis
4.2.4 Middle East and Africa – PEST Analysis
4.2.5 South and Central America – PEST Analysis
4.3 Expert Opinion
5. Global Antifungal Drugs Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Rising Prevalence of Fungal Infections
5.1.2 Increasing Incidence of Cancers, HIV, and Hospital-Acquired Infections
5.1.3 Favourable Government Initiatives to Combat the Antifungal Diseases
5.2 Key Market Restraints
5.2.1 Lack of Awareness Regarding Fungal Infections
5.3 Key Market Opportunities
5.3.1 Growing Pharmaceutical Industry in Developing Regions
5.4 Future Trends
5.4.1 Public-Private Partnerships Agreements in the Pharmaceutical Market
5.5 Impact Analysis of Drivers and Restraints
6. Antifungal Drugs Market – Global Analysis
6.1 Global Antifungal Drugs Market Revenue Forecasts And Analysis
6.2 Global Antifungal Drugs Market, By Geography - Forecasts And Analysis
6.3 Performance Of Key Players
6.4 Positioning Of Key Players
7. Antifungal Drugs Market Analysis And Forecasts To 2027 Infection Type
7.1 Overview
7.2 Global Antifungal Drugs Market Share by Infection Type 2018 & 2027 (%)
7.3 Superficial Fungal Infection
7.3.1 Overview
7.3.2 Superficial Fungal Infection Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Systemic Fungal Infection
7.4.1 Overview
7.4.2 Systemic Fungal Infection Market Revenue and Forecast to 2027 (US$ Mn)
8. Antifungal Drugs Market Analysis And Forecasts To 2027 Drug Type
8.1 Overview
8.2 Global Antifungal Drugs Market Share by Drug Type 2018 & 2027 (%)
8.3 Echinocandins
8.3.1 Overview
8.3.2 Echinocandins Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Azoles
8.4.1 Overview
8.4.2 Azoles Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Polyenes
8.5.1 Overview
8.5.2 Polyenes Market Revenue and Forecast to 2027 (US$ Mn)
8.6 Allylamines
8.6.1 Overview
8.6.2 Allylamines Market Revenue and Forecast to 2027 (US$ Mn)
8.7 Others
8.7.1 Overview
8.7.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
9. Antifungal Drugs Market Analysis And Forecasts To 2027 – Therapeutic Indication
9.1 Overview
9.2 Global Antifungal Drugs Market Share by Therapeutic Indication 2018 & 2027 (%)
9.3 Aspergillosis
9.3.1 Overview
9.3.2 Aspergillosis Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Dermatophytosis
9.4.1 Overview
9.4.2 Dermatophytosis Market Revenue and Forecast to 2027 (US$ Mn)
9.5 Candidiasis
9.5.1 Overview
9.5.2 Candidiasis Market Revenue and Forecast to 2027 (US$ Mn)
9.6 Others
9.6.1 Overview
9.6.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
10. Antifungal Drugs Market Analysis And Forecasts To 2027 Dosage Form
10.1 Overview
10.2 Global Antifungal Drugs Market Share by Dosage Form 2018 & 2027 (%)
10.3 Drugs
10.3.1 Overview
10.3.2 Drugs Market Revenue and Forecast to 2027 (US$ Mn)
10.4 Ointment
10.4.1 Overview
10.4.2 Ointment Market Revenue and Forecast to 2027 (US$ Mn)
10.5 Powder
10.5.1 Overview
10.5.2 Powder Market Revenue and Forecast to 2027 (US$ Mn)
10.6 Others
10.6.1 Overview
10.6.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
11. Antifungal Drugs Market Revenue And Forecasts To 2027 Regional Analysis
11.1 North America Antifungal drugs Market
11.1.1 Overview
11.1.2 North America Antifungal Drugs Market Revenue And Forecasts to 2027 (US$ Mn)
11.1.3 North America Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.1.4 North America Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.1.5 North America Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.1.6 North America Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.1.7 North America Antifungal drugs Market Revenue and Forecasts to 2027, By Country (%)
11.1.8 US Antifungal Drugs Market
11.1.8.1 US Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.8.2 US Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.1.8.3 US Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.1.8.4 US Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.1.8.5 US Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.1.9 Canada Antifungal Drugs Market
11.1.9.1 Canada Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.9.2 Canada Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.1.9.3 Canada Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.1.9.4 Canada Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.1.9.5 Canada Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.1.10 Mexico Antifungal Drugs Market
11.1.10.1 Mexico Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.10.2 Mexico Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.1.10.3 Mexico Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.1.10.4 Mexico Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.1.10.5 Mexico Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.2 Europe Antifungal Drugs Market
11.2.1 Overview
11.2.2 Europe Antifungal Drugs Market Revenue And Forecasts to 2027 (US$ Mn)
11.2.3 Europe Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.2.4 Europe Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.2.5 Europe Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.2.6 Europe Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.2.7 Europe Antifungal drugs Market Revenue and Forecasts to 2027, By Country (%)
11.2.8 UK Antifungal Drugs Market
11.2.8.1 UK Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.8.2 UK Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.2.8.3 UK Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.2.8.4 UK Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.2.8.5 UK Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.2.9 Germany Antifungal Drugs Market
11.2.9.1 Germany Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.9.2 Germany Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.2.9.3 Germany Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.2.9.4 Germany Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.2.9.5 Germany Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.2.10 France Antifungal Drugs Market
11.2.10.1 France Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.10.2 France Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.2.10.3 France Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.2.10.4 France Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.2.10.5 France Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.2.11 Spain Antifungal Drugs Market
11.2.11.1 Spain Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.11.2 Spain Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.2.11.3 Spain Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.2.11.4 Spain Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.2.11.5 Spain Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.2.12 Italy Antifungal Drugs Market
11.2.12.1 Italy Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.2.12.2 Italy Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.2.12.3 Italy Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.2.12.4 Italy Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.2.12.5 Italy Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.3 Asia Pacific Antifungal Drugs Market
11.3.1 Overview
11.3.2 Asia Pacific Antifungal Drugs Market Revenue And Forecasts to 2027 (US$ Mn)
11.3.3 Asia Pacific Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.3.4 Asia Pacific Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.3.5 Asia Pacific Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.3.6 Asia Pacific Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.3.7 Asia Pacific Antifungal drugs Market Revenue and Forecasts to 2027, By Country (%)
11.3.8 China Antifungal Drugs Market
11.3.8.1 China Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.8.2 China Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.3.8.3 China Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.3.8.4 China Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.3.8.5 China Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.3.9 Japan Antifungal Drugs Market
11.3.9.1 Japan Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.9.2 Japan Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.3.9.3 Japan Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.3.9.4 Japan Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.3.9.5 Japan Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.3.10 India Antifungal Drugs Market
11.3.10.1 India Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.10.2 India Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.3.10.3 India Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.3.10.4 India Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.3.10.5 India Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.3.11 Australia Antifungal Drugs Market
11.3.11.1 Australia Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.11.2 Australia Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.3.11.3 Australia Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.3.11.4 Australia Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.3.11.5 Australia Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.3.12 South Korea Antifungal Drugs Market
11.3.12.1 South Korea Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.12.2 South Korea Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.3.12.3 South Korea Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.3.12.4 South Korea Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.3.12.5 South Korea Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.4 Middle East & Africa Antifungal Drugs Market
11.4.1 Overview
11.4.2 Middle East & Africa Antifungal Drugs Market Revenue And Forecasts to 2027 (US$ Mn)
11.4.3 Middle East & Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.4.4 Middle East & Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.4.5 Middle East & Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.4.6 Middle East & Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.4.7 Middle East & Africa Antifungal drugs Market Revenue and Forecasts to 2027, By Country (%)
11.4.8 UAE Antifungal Drugs Market
11.4.8.1 UAE Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.8.2 UAE Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.4.8.3 UAE Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.4.8.4 UAE Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.4.8.5 UAE Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.4.9 Saudi Arabia Antifungal Drugs Market
11.4.9.1 Saudi Arabia Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.9.2 Saudi Arabia Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.4.9.3 Saudi Arabia Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.4.9.4 Saudi Arabia Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.4.9.5 Saudi Arabia Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.4.10 South Africa Antifungal Drugs Market
11.4.10.1 South Africa Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.4.10.2 South Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.4.10.3 South Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.4.10.4 South Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.4.10.5 South Africa Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.5 South and Central America Antifungal Drugs Market
11.5.1 Overview
11.5.2 South and Central America Antifungal Drugs Market Revenue And Forecasts to 2027 (US$ Mn)
11.5.3 South and Central America Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.5.4 South and Central America Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.5.5 South and Central America Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.5.6 South and Central America Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.5.7 South and Central America Antifungal drugs Market Revenue and Forecasts to 2027, By Country (%)
11.5.8 Brazil Antifungal Drugs Market
11.5.8.1 Brazil Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.8.2 Brazil Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.5.8.3 Brazil Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.5.8.4 Brazil Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.5.8.5 Brazil Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
11.5.9 Argentina Antifungal Drugs Market
11.5.9.1 Argentina Antifungal Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
11.5.9.2 Argentina Antifungal Drugs Market Revenue And Forecasts to 2027, By Infection Type (US$ Mn)
11.5.9.3 Argentina Antifungal Drugs Market Revenue And Forecasts to 2027, By Drug Type (US$ Mn)
11.5.9.4 Argentina Antifungal Drugs Market Revenue And Forecasts to 2027, By Therapeutic Indication (US$ Mn)
11.5.9.5 Argentina Antifungal Drugs Market Revenue And Forecasts to 2027, By Dosage Form (US$ Mn)
12. Antifungal Drugs Market– Industry Landscape
12.1 Overview
12.2 Comparative Company Analysis
12.3 Growth Strategies Done By The Companies In The Market, (%)
12.4 Recent Development Done By The Companies In The Market (2016-2019)
13. Antifungal Drugs Market–Key Company Profiles
13.1 Pfizer Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Financial Overview
13.1.4 Product Portfolio
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 NOVARTIS AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Financial Overview
13.2.4 Product Portfolio
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Merck & Co., Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Financial Overview
13.3.4 Product Portfolio
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 GlaxoSmithKline plc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Financial Overview
13.4.4 Product Portfolio
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Abbott
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Financial Overview
13.5.4 Product Portfolio
13.5.5 SWOT Analysis
13.6 BAYER AG
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Financial Overview
13.6.4 Product Portfolio
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 SANOFI S.A
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Financial Overview
13.7.4 Product portfolio
13.7.5 SWOT ANALYSIS
13.7.6 KEY DEVELOPMENTS
13.8 GILEAD SCIENCES, INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Financial Overview
13.8.4 Product Portfolio
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 SCYNEXIS, Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Financial Overview
13.9.4 Product Portfolio
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Glenmark Pharmaceuticals
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Financial Overview
13.10.4 Product Portfolio
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
Table 1. Country Estimated Burden of Candidaemia
Table 2. North America Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 3. North America Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 4. North America Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 5. North America Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 6. US Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 7. US Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 8. US Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 9. US Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 10. Canada Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 11. Canada Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 12. Canada Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 13. Canada Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 14. Mexico Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 15. Mexico Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 16. Mexico Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 17. Mexico Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 18. Europe Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 19. Europe Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 20. Europe Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 21. Europe Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 22. UK Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 23. UK Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 24. UK Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 25. UK Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 26. Germany Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 27. Germany Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 28. Germany Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 29. Germany Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 30. France Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 31. France Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 32. France Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 33. France Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 34. Spain Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 35. Spain Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 36. Spain Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 37. Spain Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 38. Italy Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 39. Italy Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 40. Italy Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 41. Italy Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 42. Asia Pacific Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 43. Asia Pacific Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 44. Asia Pacific Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 45. Asia Pacific Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 46. China Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 47. China Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 48. China Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 49. China Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 50. Japan Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 51. Japan Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 52. Japan Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 53. Japan Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 54. India Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 55. India Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 56. India Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 57. India Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 58. Australia Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 59. Australia Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 60. Australia Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 61. Australia Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 62. South Korea Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 63. South Korea Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 64. South Korea Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 65. South Korea Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 66. Middle East & Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 67. Middle East & Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 68. Middle East & Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 69. Middle East & Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 70. UAE Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 71. UAE Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 72. UAE Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 73. UAE Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 74. Saudi Arabia Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 75. Saudi Arabia Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 76. Saudi Arabia Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 77. Saudi Arabia Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 78. South Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 79. South Africa Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 80. South Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 81. South Africa Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 82. South and Central America Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 83. South and Central America Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 84. South and Central America Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 85. South and Central America Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 86. Brazil Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 87. Brazil Antifungal Drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 88. Brazil Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 89. Brazil Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 90. Argentina Antifungal Drugs Market Revenue And Forecasts To 2027, By Infection Type (US$ Mn)
Table 91. Argentina Antifungal drugs Market Revenue And Forecasts To 2027, By Drug Type (US$ Mn)
Table 92. Argentina Antifungal Drugs Market Revenue And Forecasts To 2027, By Therapeutic Indication (US$ Mn)
Table 93. Argentina Antifungal Drugs Market Revenue And Forecasts To 2027, By Dosage Form (US$ Mn)
Table 94. Recent Development Done By The Companies In The Market
Table 95. Glossary of Terms, Antifungal Drugs Market
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
